Specific Reveal AST system designated a breakthrough device

Create PDF

Aug. 24, 2022—BioMérieux announced that its Specific Reveal rapid antimicrobial susceptibility test system has received breakthrough device designation from the FDA.

The test system provides phenotypic antibiotic susceptibility test results directly from a positive blood culture in about 5.5 hours.